Elevated levels of plasma homocysteine in postmenopausal women in Burkina Faso

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 7, 2005, Pages 765-771

  Chillemi, Rosa ^a   Simpore, Jacques ^b   Persichilli, Silvia ^c   Minucci, Angelo ^c   D'Agata, Alfonsina ^a   Musumeci, Salvatore ^d,e  

^a UNIVERSITY OF CATANIA   (Italy)

^b Medical Center Saint Camille   (Burkina Faso)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e CNR   (Italy)

Author keywords

Burkina Faso; Homocysteine; Postmenopausal women

Indexed keywords

CREATININE; CYANOCOBALAMIN; CYSTATIN C; CYSTEINE; CYSTEINYLGLYCINE; FOLIC ACID; GLUTATHIONE; HOMOCYSTEINE; THIOL DERIVATIVE;

ADULT; AGE; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FEMALE FERTILITY; FOLIC ACID BLOOD LEVEL; HUMAN; ITALY; METABOLISM; POSTMENOPAUSE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD CHEMICAL ANALYSIS; BURKINA FASO; CORONARY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; MENOPAUSE; MIDDLE AGED; SULFHYDRYL COMPOUNDS;

EID: 26844468045     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.131     Document Type: Article

References (42)

1. Scriver CR, Beaudet AL, Sly WS, Valle D. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw Hill, 1995:1279-327.
2. Mayer EL, Jacobsen DW, Robinson K. Hcy and coronary atherosclerosis J Am Coll Cardiol 1996;27:517-27.
3. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49:31-62.
4. Neufeld EJ. Update on genetic risk factors for thrombosis and atherosclerotic vascular disease. Hematol Oncol Clin N Am 1998;12:1193-209.
5. Prasad K. Homocysteine, a risk factor for cardiovascular disease. Int J Angiol 1999;8:76-86.
6. 6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg 1994; 20:933-40.
7. Den Heijer M, Brouwer IA, Bos GM, Blom HJ, Van der Put NM, Spaans AP, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscl Thromb Vasc Biol 1998;18:356-61.
8. Ubbink JB, Vermaak WJ, Van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-33.
9. Malinow MR, Bostom AG, Krauss RM. Homocysteine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82.
10. Simpore J, Pignatelli S, Barlati S, Malaguarnera M, Musumeci S. Plasma homocysteine concentrations in a healthy population living in Burkina Faso. Curr Ther Res 2000;61:659-68.
11. Bjorkegren K, Svardsudd K. Elevated serum levels of methylmalonic acid and homocysteine in elderly people. A population-based intervention study. J Intern Med 1999;246:603-11.
12. Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801-5.
13. Malaguarnera M, Pistone G, Motta M, Vinci E, Oreste G, Avellone G, et al. Elevated plasma total homocysteine in centenarians. Clin Chem Lab Med 2004;42:307-10.
14. Ligthart GJ, Corberand JX, Geertzen HG, Meinders AE, Knook DL, Hijmans W. Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Ageing Dev 1990;55:89-105.
15. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
16. Simpore J, Pignatelli S, Meli C, Malaguarnera M, Chillemi R, Musumeci S. Nutritional and racial determinants of the increase in plasma homocysteine levels after methionine loading. Curr Ther Res 2002;63:459-73.
17. Ubbink JB, Delport R, Vermaak WJ. Effective homocysteine metabolism may protect South African blacks against heart disease. Am J Clin Nutr 1996;62:802-8.
18. Ubbink JB, Delport R, Vermaak WJ. Plasma homocysteine concentration in a population with a low coronary heart disease prevalence. J Nutr 1996;126:1254S-7S.
19. Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Total homocysteine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke 1998;29:2473-7.
20. 6 occur commonly in elderly people. Am J Clin Nutr 1993;58:468-76.
21. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 1993;270:2693-8.
22. Nilsson K, Gustafson L, Hultberg B. Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamines and folates in a psychogeriatric population. Dement Geriatr Cogn Disord 1999;10:476-82.
23. Sadewa AH, Sunarti, Sutomo R, Hayashi C, Lee MJ, Ayaki H, et al. The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population. Kobe J Med Sci 2002;48:137-44.
24. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000;151:862-77.
25. Amouzou EK, Chabi NW, Adjalla CE, Rodriguez-Gueant RM, Feillet F, Villaume C, et al. High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C→T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am J Clin Nutr 2004;79:619-24.
26. Shaw GM, Rosen R, Finnel RH, Wasserman CR, Lammer EJ. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase and risk for spina bifida. Am J Epidemiol 1998;148:30-7.
27. Pallaud C, Stranieri C, Sass C, Siest G, Pignatti F, Visvikis S. Candidate gene polymorphisms in cardiovascular disease: a comparative study of frequencies between a French and an Italian population. Clin Chem Lab Med 2001;39:146-54.
28. Chillemi R, Zappacosta B, Simpore J, Persichilli S, Musumeci M, Musumeci S. Hyperhomocysteinemia in acute Plasmodium falciparum malaria: an effect of host-parasite interaction. Clin Chim Acta 2004;348:113-20.
29. Ghandour H, Bagley PJ, Shemin D, Hsu N, Jacques PF, Dworkin L, et al. Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid. Kidney Int 2002;62:2246-9.
30. Mizuno Y, Kawazu SI, Kano S, Watanabe N, Matsuura T, Ohtomo H. In-vitro uptake of vitamin A by Plasmodium falciparum. Ann Trop Med Parasitol 2003;97:237-43.
31. Delmas-Beauvieux MC, Peuchant E, Dumon MF, Receveur MC, Le Bras M, Clerc M. Relationship between red blood cell antioxidant enzymatic system status and lipoperoxidation during the acute phase of malaria. Clin Biochem 1995;28:163-9.
32. Droge W. The plasma redox state and ageing. Ageing Res Rev 2002;1:257-78.
33. Erden-Inal M, Sunal E, Kanbak G. Age-related changes in the glutathione redox system. Cell Biochem Funct 2002;20:61-6.
34. Schwenke DC. Aging, menopause, and free radicals. Semin Reprod Endocrinol 1998;16:281-308.
35. Spotila LD, Jacques PF, Berger PB, Ballman KV, Ellison RC, Rozen R. Age dependence of the influence of methylenetetrahydrofolate reductase genotype on plasma homocysteine level. Am J Epidemiol 2003;158:871-7.
36. Mager A, Lalezari S, Shohat T, Birnbaum Y, Adler Y, Magal N, et al. Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease. Circulation 1999;100:2406-10.
37. Sobczak A, Wardas W, Zielinska-Danch W, Pawlicki K. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers. Clin Chem Lab Med 2004;42:408-14.
38. Pisciotta L, Cantafora A, Piana A, Masturzo P, Cerone R, Minniti G, et al. Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years. Nutr Metab Cardiovasc Dis 2003;13:202-10.
39. Stehouwer CD, van Guldener C. Does homocysteine cause hypertension? Clin Chem Lab Med 2003; 41:1408-11.
40. Prigge ST, Chiang PK. S-Adenosylhomocysteine hydrolase. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge University Press, Cambridge, 2001:79-91.
41. Riksen NP, Rongen GA, Blom HJ, Russel FG, Boers GH, Smits P. Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia. Cardiovasc Res 2003;59:271-6.
42. Simorre B, Quere I, Berrut G, Chasse JF, Bellet H, Kamoun P, et al. Vascular complications of homocystinuria: a retrospective multicenter study. Rev Med Intern 2002;23:267-72.